Comparative Safety and effectiveness of long-acting muscarinic antagonists for chronic obstructive pulmonary disease (COPD): a rapid review and network meta-analysis
Tricco AC, Strifler L, Yazdi F, Khan P, Ng C, Antony J, Mrklas K, Scott A, D’Souza J, Cardoso R. Comparative safety and effectiveness of long-acting muscarinic antagonists for chronic obstructive pulmonary disease (COPD): a rapid review and network meta-analysis. Technical Report 2014.
[sidebar] Commissioned and Funded by: Ontario Drug Policy Research Network (ODPRN) and Ontario Ministry of Health and Long-Term Care (OMHLTC)
[/no-bottom-margin]
Share Buttons [span][/span]
[ssba-buttons] [/sidebar] [sidebar-content]- Our results can be used by patients and physicians to tailor administration of these agents
- Commissioned by the Ontario Drug Policy Research Network to inform the listing of these agents by the Ontario Public Drug Program
- The results of a network meta-analysis (NMA) restricted to patients with moderate chronic obstructive pulmonary disease (COPD) found that tiotropium+formoterol had the highest probability of reducing the risk of exacerbations
Related Projects:
[/sidebar-content]Category : KS Projects
Date : 03 Sep 2020